Home

Aurobindo Pharma Ltd Quarterly Result

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

Net Profit - Last Quarter

₹ 816.95 Cr.

Last updated on: Jan 22, 2025

Aurobindo Pharma Ltd Quarterly Results Key Highlights

  • The revenue of Aurobindo Pharma Ltd for the Sep '24 is ₹ 7932 crore as compare to the Jun '24 revenue of ₹ 7787 crore.
  • This represent the growth of 1.85%a1# The ebitda of Aurobindo Pharma Ltd for the Sep '24 is ₹ 1702 crore as compare to the Jun '24 ebitda of ₹ 1839 crore.
  • This represent the decline of -7.43%a1# The net profit of Aurobindo Pharma Ltd for the Sep '24 is ₹ 816.95 crore as compare to the Jun '24 net profit of ₹ 918.22 crore.
  • This represent the decline of -11.03%a1#.

Aurobindo Pharma Ltd Quarterly Results Analysis

Market Price of Aurobindo Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Jan 20251191.2
21 Jan 20251186.7
20 Jan 20251202.7
17 Jan 20251177.85
16 Jan 20251156.6
15 Jan 20251147.35
14 Jan 20251174.9
13 Jan 20251161.85
10 Jan 20251200.1
09 Jan 20251248.7

Historical Revenue of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Aurobindo Pharma Ltd

No data available

* All values are in crore

Aurobindo Pharma Ltd News Hub

Aurobindo Pharma tumbles after US FDA issues warning letter to Telangana unit

In May 2024, the United States Food and Drug Administration (US FDA) had conducted an inspection at

Read more

16 Aug 2024

Eugia Pharma Specialities receives USFDA warning for Unit III

Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugia Pharma S

Read more

16 Aug 2024

Aurobindo Pharma consolidated net profit rises 61.05% in the June 2024 quarter

Net profit of Aurobindo Pharma rose 61.05% to Rs 919.22 crore in the quarter ended June 2024 as agai

Read more

12 Aug 2024

Auro Pharma gets USFDA nod for atrophic vaginitis drug

The approved drug is bioequivalent and therapeutically equivalent to the reference listed drug (RLD)

Read more

07 Aug 2024

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

FAQs for Quarterly Results of Aurobindo Pharma Ltd

What key financial metrics are included in Aurobindo Pharma Ltd's quarterly results?

Key financial metrics in Aurobindo Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Aurobindo Pharma Ltd announce its quarterly results?

Aurobindo Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Aurobindo Pharma Ltd's quarterly performance impact its stock price?

Aurobindo Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Aurobindo Pharma Ltd's quarterly results on dividends?

The impact of Aurobindo Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Aurobindo Pharma Ltd's quarterly results?

Yes, Aurobindo Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions